UK markets closed

BRAIN Biotech AG (0RFI.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
5.66+0.14 (+2.54%)
At close: 02:37PM GMT
Full screen
Loading interactive chart…
  • EQS Group

    BRAIN Biotech AG: MP Beteiligungs-GmbH Increases Stake in BRAIN Biotech AG

    EQS-News: BRAIN Biotech AG / Key word(s): MiscellaneousBRAIN Biotech AG: MP Beteiligungs-GmbH Increases Stake in BRAIN Biotech AG 17.11.2022 / 10:00 CET/CESTThe issuer is solely responsible for the content of this announcement.MP Beteiligungs-GmbH Increases Stake in BRAIN Biotech AG Block transaction recently successfully closed MP Beteiligungs-GmbH has increased its holding throughout 2022 Long-term supporter of the development of BRAIN Biotech AGZwingenberg, November 17, 2022 – BRAIN Biotech A

  • EQS Group

    BRAIN Biotech and Bonumose collaborate on enzymes for the production of rare monosaccharides

    EQS-News: BRAIN Biotech AG / Key word(s): AllianceBRAIN Biotech and Bonumose collaborate on enzymes for the production of rare monosaccharides 25.10.2022 / 09:30 CET/CESTThe issuer is solely responsible for the content of this announcement.BRAIN Biotech and Bonumose collaborate on enzymes for the production of rare monosaccharidesZwingenberg, Germany and Charlottesville, VA, USA, 25 October 2022 – BRAIN Biotech AG, a leading European industrial biotechnology specialist, and rare sugars expert Bo

  • EQS Group

    Change in the Executive Management Board of BRAIN Biotech AG, genome editing activities established under the Akribion Genomics brand

    EQS-News: BRAIN Biotech AG / Key word(s): Personnel/Strategic Company DecisionChange in the Executive Management Board of BRAIN Biotech AG, genome editing activities established under the Akribion Genomics brand 27.09.2022 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement. Lukas Linnig stepping down as CFO. Michael Schneiders to become new CFO of BRAIN Biotech AG as of October 1st, 2022 Lukas Linnig and Dr. Michael Krohn to jointly lead Akribion Genomics activ